Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Neumann-Haefelin

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
JHEP Reports : Innovation in Hepatology|April 26, 2026
Robust HLA-B-restricted CD8+ T cell responses in chronic HBV infectionJulia Lang-Meli, Anna-Lena Denecke, Johannes Ptok, et al.
Journal of Hepatology|August 28, 2022
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Beat Müllhaupt, Peter Buggisch, et al.
Nature Communications|August 8, 2022
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivationMatthias Reinscheid, Hendrik Luxenburger, Vivien Karl, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2019
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 InfectionsJulia Dietz, Ulrich Spengler, Beat Müllhaupt, et al.
Gut|August 4, 2023
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8<sup>+</sup> T cellsFrances Winkler, Anna V Hipp, Carlos Ramirez, et al.
Frontiers in Immunology|November 28, 2022
Immune escape pathways from the HBV core<sub>18-27</sub> CD8 T cell response are driven by individual HLA class I allelesAndreas Walker, Tatjana Schwarz, Janine Brinkmann-Paulukat, et al.
Nature Microbiology|April 28, 2022
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individualsJulia Lang-Meli, Hendrik Luxenburger, Katharina Wild, et al.
Immunity|June 26, 2021
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactionsMarius Schwabenland, Henrike Salié, Jovan Tanevski, et al.
Liver Cancer|October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score AnalysisDominik Bettinger, David J Pinato, Michael Schultheiss, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
JHEP Reports : Innovation in Hepatology|April 26, 2026
Robust HLA-B-restricted CD8+ T cell responses in chronic HBV infectionJulia Lang-Meli, Anna-Lena Denecke, Johannes Ptok, et al.
Journal of Hepatology|August 28, 2022
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Beat Müllhaupt, Peter Buggisch, et al.
Nature Communications|August 8, 2022
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivationMatthias Reinscheid, Hendrik Luxenburger, Vivien Karl, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2019
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 InfectionsJulia Dietz, Ulrich Spengler, Beat Müllhaupt, et al.
Gut|August 4, 2023
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8<sup>+</sup> T cellsFrances Winkler, Anna V Hipp, Carlos Ramirez, et al.
Frontiers in Immunology|November 28, 2022
Immune escape pathways from the HBV core<sub>18-27</sub> CD8 T cell response are driven by individual HLA class I allelesAndreas Walker, Tatjana Schwarz, Janine Brinkmann-Paulukat, et al.
Nature Microbiology|April 28, 2022
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individualsJulia Lang-Meli, Hendrik Luxenburger, Katharina Wild, et al.
Immunity|June 26, 2021
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactionsMarius Schwabenland, Henrike Salié, Jovan Tanevski, et al.
Liver Cancer|October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score AnalysisDominik Bettinger, David J Pinato, Michael Schultheiss, et al.
Pageof 14